News | October 23, 2023
RPG Life Sciences posts Q2 FY24 PAT at Rs. 25.86 Cr
RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023
RPG Life Sciences has reported total income of Rs. 155.41 crores during the period ended September 30, 2023
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
In Q2 FY23, the overall performance of the company continued to be strong despite the ongoing geo-political challenges impacting supply chain and costs
The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.
The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021
He has previously served in pivotal HR leadership roles at RPG Life Sciences, Akumentis Healthcare, and Wockhardt
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Sanjay Verma of Akums Drugs & Pharmaceuticals, Manu Gupta of Cadila Pharmaceuticals, Rahul Borse of RPG Life Sciences, Krishna Sai T of Biocon and Amit Saluja of NASSCOM are speakers
Subscribe To Our Newsletter & Stay Updated
